Literature DB >> 11761481

Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.

M Nagai1, Y Yamano, M B Brennan, C A Mora, S Jacobson.   

Abstract

To date, high human T-cell lymphotropic virus type I proviral load in patients with human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis has been reported and is thought to be related to the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. However, the proviral load in cerebrospinal fluid has not been well investigated. We measured human T-cell lymphotropic virus type I proviral load in cerebrospinal fluid cells from human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis patients using real-time quantitative polymerase chain reaction (TaqMan). Human T-cell lymphotropic virus type I proviral load in cerebrospinal fluid cells were significantly higher than that of the matched peripheral blood mononuclear cells, and a high ratio of human T-cell lymphotropic virus type I proviral load in cerebrospinal fluid cells to peripheral blood mononuclear cells were observed in patients with short duration of illness. Human T-cell lymphotropic virus type I Tax-specific CD8+ T cells, as detected by peptide-loaded HLA tetramers, accumulated in cerebrospinal fluid compared with that in peripheral blood mononuclear cells, while the frequency of cytomegalovirus-specific CD8+ T cells in cerebrospinal fluid was reduced. These observations suggest that accumulation of both human T-cell lymphotropic virus type I-infected cells and preferential expansion of human T-cell lymphotropic virus type I-specific CD8+ cells in cerebrospinal fluid may play a role in the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11761481     DOI: 10.1002/ana.10065

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  63 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

Review 2.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells.

Authors:  Julie M Johnson-Nauroth; Jerome Graber; Karen Yao; Steve Jacobson; Peter A Calabresi
Journal:  J Neuroimmunol       Date:  2006-06-05       Impact factor: 3.478

4.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Kory R Johnson; Elizabeth M Maloney; Steven Jacobson
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

5.  Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.

Authors:  Risaku Fukumoto; Miroslav Dundr; Christophe Nicot; Anthony Adams; Valerio W Valeri; Lawrence E Samelson; Genoveffa Franchini
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

6.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

7.  High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.

Authors:  Yoshimi Enose-Akahata; Eiji Matsuura; Unsong Oh; Steven Jacobson
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

8.  Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Mineki Saito
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-10

9.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.